A Multicentre study of anticoagulation in operable chronic thromboembolic pulmonary hypertension.

CONCLUSIONS: Post-PEA functional and haemodynamic outcomes appear unaffected by anticoagulant choice. Bleeding events were similar, but recurrent VTE rates significantly higher in those receiving DOACs. Our study provides a strong rationale for prospective registry data and/or studies to evaluate the safety of DOACs in CTEPH.
PMID: 31557382 [PubMed - as supplied by publisher]

Source: Thrombosis and Haemostasis - September 25, 2019 Category: Hematology Authors: Bunclark K, Newnham M, Chiu YD, Ruggiero A, Villar SS, Cannon JE, Coghlan G, Corris PA, Howard L, Jenkins D, Johnson M, Kiely DG, Ng C, Screaton N, Sheares K, Taboada D, Tsui S, Wort JS, Pepke-Zaba J, Toshner M Tags: J Thromb Haemost Source Type: research